KR101644333B1 - Method for producing uncooked food pill containing myrrh and frankincense and uncooked food pill produced by the same method - Google Patents
Method for producing uncooked food pill containing myrrh and frankincense and uncooked food pill produced by the same method Download PDFInfo
- Publication number
- KR101644333B1 KR101644333B1 KR1020160030685A KR20160030685A KR101644333B1 KR 101644333 B1 KR101644333 B1 KR 101644333B1 KR 1020160030685 A KR1020160030685 A KR 1020160030685A KR 20160030685 A KR20160030685 A KR 20160030685A KR 101644333 B1 KR101644333 B1 KR 101644333B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- prepared
- myrrh
- mixed
- hours
- Prior art date
Links
- 240000007311 Commiphora myrrha Species 0.000 title claims abstract description 39
- 235000006965 Commiphora myrrha Nutrition 0.000 title claims abstract description 39
- 235000007265 Myrrhis odorata Nutrition 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 17
- 238000004519 manufacturing process Methods 0.000 title abstract description 27
- 240000007551 Boswellia serrata Species 0.000 title abstract description 16
- 235000003717 Boswellia sacra Nutrition 0.000 title abstract description 12
- 235000012035 Boswellia serrata Nutrition 0.000 title abstract description 12
- 239000004863 Frankincense Substances 0.000 title abstract description 12
- 235000013305 food Nutrition 0.000 title abstract description 5
- 239000006187 pill Substances 0.000 title abstract 4
- 239000000284 extract Substances 0.000 claims abstract description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 24
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000018865 Angelica gigas Nutrition 0.000 claims abstract description 17
- 240000001810 Angelica gigas Species 0.000 claims abstract description 17
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 15
- 240000000249 Morus alba Species 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 15
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims abstract description 14
- 239000000052 vinegar Substances 0.000 claims abstract description 13
- 235000021419 vinegar Nutrition 0.000 claims abstract description 13
- 235000014066 European mistletoe Nutrition 0.000 claims abstract description 9
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 9
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 9
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 9
- 244000152640 Rhipsalis cassutha Species 0.000 claims abstract description 9
- 235000012300 Rhipsalis cassutha Nutrition 0.000 claims abstract description 9
- 229940010454 licorice Drugs 0.000 claims abstract description 9
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- 240000004670 Glycyrrhiza echinata Species 0.000 claims abstract description 8
- 240000004371 Panax ginseng Species 0.000 claims abstract description 8
- 235000021329 brown rice Nutrition 0.000 claims abstract description 8
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 7
- 235000008434 ginseng Nutrition 0.000 claims abstract description 7
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- 244000291564 Allium cepa Species 0.000 claims abstract 5
- 238000001035 drying Methods 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 11
- 241000332371 Abutilon x hybridum Species 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 7
- 240000009088 Fragaria x ananassa Species 0.000 claims description 7
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 7
- 239000011888 foil Substances 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 210000001161 mammalian embryo Anatomy 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000004898 kneading Methods 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 3
- 235000002566 Capsicum Nutrition 0.000 claims description 3
- 235000003228 Lactuca sativa Nutrition 0.000 claims description 3
- 240000008415 Lactuca sativa Species 0.000 claims description 3
- 239000006002 Pepper Substances 0.000 claims description 3
- 235000016761 Piper aduncum Nutrition 0.000 claims description 3
- 240000003889 Piper guineense Species 0.000 claims description 3
- 235000017804 Piper guineense Nutrition 0.000 claims description 3
- 235000008184 Piper nigrum Nutrition 0.000 claims description 3
- 239000012267 brine Substances 0.000 claims description 3
- 235000013869 carnauba wax Nutrition 0.000 claims description 3
- 239000004203 carnauba wax Substances 0.000 claims description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims description 3
- 230000035558 fertility Effects 0.000 claims 1
- 238000000605 extraction Methods 0.000 abstract description 8
- 244000234609 Portulaca oleracea Species 0.000 abstract description 2
- 235000001855 Portulaca oleracea Nutrition 0.000 abstract description 2
- 240000005748 Achyranthes aspera Species 0.000 abstract 1
- 235000005517 Achyranthes aspera Nutrition 0.000 abstract 1
- 241000756943 Codonopsis Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 241000202564 Kalopanax Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 240000003582 Platycodon grandiflorus Species 0.000 abstract 1
- 241000267040 Sasa borealis Species 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 32
- 230000000052 comparative effect Effects 0.000 description 18
- 235000012000 cholesterol Nutrition 0.000 description 14
- 239000000463 material Substances 0.000 description 10
- 241000234282 Allium Species 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 9
- 230000002710 gonadal effect Effects 0.000 description 9
- 210000002149 gonad Anatomy 0.000 description 8
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 235000005911 diet Nutrition 0.000 description 6
- 230000037213 diet Effects 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 230000002070 germicidal effect Effects 0.000 description 5
- 235000018062 Boswellia Nutrition 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 108010023302 HDL Cholesterol Proteins 0.000 description 4
- 108010028554 LDL Cholesterol Proteins 0.000 description 4
- 238000008214 LDL Cholesterol Methods 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 230000001850 reproductive effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 244000056139 Brassica cretica Species 0.000 description 2
- 235000003351 Brassica cretica Nutrition 0.000 description 2
- 235000003343 Brassica rupestris Nutrition 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 102000006771 Gonadotropins Human genes 0.000 description 2
- 108010086677 Gonadotropins Proteins 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 235000010724 Wisteria floribunda Nutrition 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000020974 cholesterol intake Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 239000002622 gonadotropin Substances 0.000 description 2
- 229940094892 gonadotropins Drugs 0.000 description 2
- 230000008821 health effect Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000010460 mustard Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- NBGQZFQREPIKMG-UHFFFAOYSA-N 3beta-hydroxy-beta-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C NBGQZFQREPIKMG-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- NBGQZFQREPIKMG-PONOSELZSA-N Boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C NBGQZFQREPIKMG-PONOSELZSA-N 0.000 description 1
- 241000208229 Burseraceae Species 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 241000159174 Commiphora Species 0.000 description 1
- 241000159188 Commiphora habessinica Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000001860 Eye Infections Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000002725 Olea europaea Nutrition 0.000 description 1
- 206010048685 Oral infection Diseases 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000006751 Platycodon Nutrition 0.000 description 1
- 244000274050 Platycodon grandiflorum Species 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 240000005499 Sasa Species 0.000 description 1
- 241000534017 Saururus chinensis Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- BZXULBWGROURAF-UHFFFAOYSA-N alpha-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC3C21C BZXULBWGROURAF-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960004874 choline bitartrate Drugs 0.000 description 1
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000007882 dietary composition Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 208000011323 eye infectious disease Diseases 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- WAFDWKYNSTVECG-UHFFFAOYSA-L magnesium;3-[(4-nitrophenyl)methoxy]-3-oxopropanoate Chemical compound [Mg+2].[O-]C(=O)CC(=O)OCC1=CC=C([N+]([O-])=O)C=C1.[O-]C(=O)CC(=O)OCC1=CC=C([N+]([O-])=O)C=C1 WAFDWKYNSTVECG-UHFFFAOYSA-L 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 231100000544 menstrual irregularity Toxicity 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 229940016409 methylsulfonylmethane Drugs 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 239000008601 oleoresin Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229930189914 platycodon Natural products 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000021487 ready-to-eat food Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A23L1/3002—
-
- A23L1/0017—
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/3262—Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
The present invention relates to a method for producing a reproductive organs, which is produced by using myrrh, frankincense, brown rice embryo, chrysanthemum morifolium, mulberry leaf, mustard, carrot, dimethyl sulfone, The present invention relates to a method for producing a ring and a germicidal ring produced by the method. The germicidal ring of the present invention is excellent in blood circulation improving effect, and can be provided with a reproductive ring which is excellent in taste and aroma and can be easily ingested have.
Myrrh (myrrh) is a bitter, fragrant, yellowish reddish brown resin (oleoresin) rubber. It is obtained from a small, thorny flowering arboreum of the Commiphora or a plant of the family Burseraceae such as Commiphora myrrha or Commiphora abyssinica, It is distinguishable from the plant (Commiphora myrrha).
Myrrh is widely used in cosmetics such as fragrance, fragrance, fragrance, fragrance of perfume, and medicinal materials, and it is used in the ancient Near East, the Middle East and the Middle Europe It was very precious. For the common people, it is famous in the Christian scriptures that the Magi presented gold, frankincense, and myrrh to the baby Jesus.
As a medicinal use, it has been mainly used in the treatment of oral infection and inflammation. It is known that mouthwash or toothpaste containing myrrh is effective for treating gingivitis. It is said to be used as a topical application, preventing mouth, teeth and eye infections. In Egypt, it was an essential flavor used as a preservative in making mummies. Prior to the first century BC, myrrh was used to prevent wine from becoming fermented and vinegar, while in Greece and Rome it was prescribed as an effective remedy for snakebite. Indians use myrrh for treatment of circulatory disorders, neurological disorders, arthritis, etc. In the West, myrrh has been recognized as a substance that relieves the pain of the body and accelerates the healing process, giving a strong preservative effect.
Boswellia carterii Birdwood is a dried fruit of the oriental tree belonging to the olive tree. It is scratched when it is stuck in the air by putting a milk juice like a milk which comes out from a tree trunk and scatters it, and it dries it. Sulfur causes blood circulation, stops pain, cramps, bruises, swelling, dysmenorrhea, menstrual irregularities, and postpartum abdominal pain. When used as an external medicine, it is made into powder or sprinkled or put on a foundation. The flavor is delicious, the nature is warm, and the vinegar is the heart, the liver, and the lung. The efficacy of frankincense (动血 止痛) is the clinical application of pain due to hemorrhoids are applied.
The frankincense is mainly composed of α-boswellic acid, β-boswellic acid, β-pinene, dipentene, This is known as an excellent medicinal product. In addition, frankincense is a resin of fragrance and it is effective for powerful analgesic action, nervous stability, dysmenorrhea, tumor, dermatitis.
Korean Patent Publication No. 0881367 discloses a method for producing a gonadal ring containing Hwasungcho and Saururus chinensis, Korean Patent Publication No. 2005-0097027 discloses a method for producing a functional gonadal ring, This method is different from the method of manufacturing a germicidal ring.
SUMMARY OF THE INVENTION The present invention has been made in view of the above-mentioned needs, and an object of the present invention is to provide a method of manufacturing a germicidal composition having improved blood circulation and favorable taste, by optimizing manufacturing conditions such as selection of health-oriented functional plant materials, pretreatment, And to provide a new type of reproductive system capable of easily increasing the degree of preference and expecting the health promotion effect.
In order to solve the above-described problems, the present invention provides a method for preparing a mixed extract, comprising: (a) preparing a mixed extract by pulverizing an extract foil and an extract after water is added to the bellflower, onion and lettuce; (b) preparing an extract by adding water to a spatula, strawberry, mistletoe, sea tangle and licorice; (c) immersing myrrh and oriental in vinegar or alcohol, heat-treating, removing and drying; (d) immersing the true Angelica gigas in a salt water, taking it out and preparing it for roasting; And (e) mixing the dry myrrh and the oriental preparation prepared in the step (c), the prepared Angelica gigas and the brown rice germ powder prepared in the step (d), the dried ginseng, the mulberry leaf, the kneaded kneader and the pepper and the dimethyl sulfone, And mixing and kneading the mixed extract prepared in step (a) and the extract prepared in step (b), followed by washing and drying, and then drying the kneaded product.
The present invention also provides a germ circle produced by the above method.
The germplasm of the present invention can provide an optimal health-oriented functional material among the troublesome plant materials that are consumed as food, and can provide a germ meal which is excellent in taste and aroma and can be easily ingested. In addition, the method of the present invention is advantageous in that the materials can be pretreated and there is no pungent taste and odor peculiar to the material, so that it is easy to take and the effective ingredient can be enhanced. In addition, the germplasm of the present invention can be expected to be a ready-to-eat food that can be easily stored at room temperature because it is a health food that can obtain a health-promoting effect over the long term such as blood circulation improvement.
In order to achieve the object of the present invention,
(a) adding water to the bellflower, onion and lettuce, and then pulverizing the extract foil and the extract to prepare a mixed extract;
(b) preparing an extract by adding water to a spatula, strawberry, mistletoe, sea tangle and licorice;
(c) immersing myrrh and oriental in vinegar or alcohol, heat-treating, removing and drying;
(d) immersing the true Angelica gigas in a salt water, taking it out and preparing it for roasting; And
(e) mixing the dry myrrh powder and the oriental preparation of step (c), the prepared Angelica gigas and the brown rice embryo powder prepared in step (d), the dried ginseng, the mulberry leaf, the kneader and the pepper and the dimethyl sulfone, mixing the prepared mixed extract prepared in step (a) with the extract prepared in step (b), kneading the mixture, and washing and drying the kneaded mixture.
In the method for producing a gonadal ring of the present invention, the extraction of step (a) is preferably carried out at 50 to 60 ° C for 66 to 78 hours, more preferably at 50 to 60 ° C for 72 hours have. Under the above conditions, the extraction of platycodon, Onion and Doduck extracts at low temperature resulted in the extraction of a large amount of active ingredient without destroying the nutrients.
In addition, in the method for producing a gonadal ring of the present invention, the extraction in step (b) may preferably be carried out at 80 to 90 ° C for 55 to 65 hours, more preferably at 80 to 90 ° C for 60 hours can do. Extraction of materials under the above conditions could be made with a reduced content of bitterness and odor while containing a large amount of active ingredient.
Also, in the method for manufacturing a gonadal ring of the present invention, the step (c) is preferably performed by immersing myrrh and an oriental form into vinegar or sake for 20 to 28 hours, heat-treating the article at 90 to 140 ° C for 1 to 3 hours, More preferably, the myrrh and the fragrance may be immersed in vinegar or sake for 24 hours, then heat-treated at 90 to 140 ° C for 2 hours, and then taken out and dried. Pretreatment of myrrh and oriental mud under the above conditions could effectively improve the active ingredient while effectively eliminating toxicity contained in myrrh and oriental.
In addition, in the method for producing a gonadal ring of the present invention, the step (d) may preferably be carried out by immersing the Angelica gigas Nakai in a salt water for 44 to 52 hours, and then preparing it for roasting. More preferably, After immersion for a period of time, it can be taken out and prepared for roasting. The pretreatment of Angelica gigas Nakai under the above conditions was able to further enhance the effectiveness, flavor and taste of Angelica gigas Nakai.
More specifically, the method for producing a gonadal ring of the present invention
(a) Water is added to 130 to 180 g of bellflower, 140 to 210 g of onion, 130 to 190 g of onion, and the mixture is extracted at 50 to 60 ° C for 66 to 78 hours, followed by pulverizing the extracted foil and the extract to prepare a mixed extract ;
(b) water was added to 110 to 170 g of a strawberry sash, 110 to 170 g of strawberry, 110 to 170 g of mistletoe, 110 to 170 g of a green paste, and 110 to 160 g of licorice, followed by extraction at 80 to 90 ° C for 55 to 65 hours Preparing an extract;
(c) immersing 160 to 240 g of mols and 120 to 170 g of mushroom in vinegar or sake for 20 to 28 hours, followed by heat treatment at 90 to 140 ° C for 1 to 3 hours, and then taking out and drying;
(d) immersing 130 to 180 g of Angelica gigas Nakai in brine for 44 to 52 hours, taking out and preparing for roasting; And
(e) 150 to 220 g of the dry myrrh powder and the scent of step (c) prepared in the above step (d), and 120 to 180 g of the mulberry leaf, 120 to 180 g of the mulberry leaf 115 to 175 g of carnauba wax and 115 to 175 g of dimethyl sulfone are mixed and powdered. The mixed extract prepared in step (a) and the extract prepared in step (b) are mixed and kneaded, , ≪ / RTI >
More specifically,
(a) Water is added to 155 g of bellflower, 175 g of onion, 160 g of onion, and the mixture is extracted at 50 to 60 ° C for 72 hours, followed by pulverizing the extracted foil and the extract to prepare a mixed extract;
(b) adding water to 140 g of Strawberry Sorbet, 140 g of Mulberry, 140 g of Mistletoe, 140 g of Solvent Puff and 135 g of Licorice, and extracting at 80 to 90 ° C for 60 hours to prepare an extract;
(c) immersing 200 g of myrrh and 145 g of myrrh for 24 hours in vinegar or sake, followed by heat treatment at 90 to 140 ° C for 2 hours, and then taking out and drying;
(d) immersing 156 g of Angelica gigas coriae in brine for 48 hours, taking out and preparing for roasting; And
(e) 183 g of the dry myrrh powder and the frankincense prepared in the step (c), 183 g of the Angelica gigas and the brown rice germ powder prepared in the step (d), 153 g of the dried ginseng, 150 g of the mulberry leaf, 148 g of the mustard, g, and then mixing the resultant mixture with the extract prepared in the step (a) and the extract prepared in the step (b), kneading the mixture, and then washing and drying.
In the method for producing a gonadal ring according to the present invention, the gonadal rings manufactured by the materials and the blending ratios of the above (a) to (e) are excellent in health promoting effects such as improvement of blood circulation and have no peculiar taste and odor So that the degree of preference was improved.
The present invention also provides a germ circle produced by the above method.
Hereinafter, embodiments of the present invention will be described in detail. However, the following examples are illustrative of the present invention, and the present invention is not limited to the following examples.
Manufacturing example One: Reproductive cycle Produce
(1) The brown rice embryo germinated by germination was dried in cold air to prepare powder.
(2) Water was added to the bellflower, onion and thyme, and the mixture was extracted at 50 to 60 ° C for 72 hours to prevent the nutrients from being destroyed by the vacuum extractor. The extract and the extract were ground with a large blender to prepare a mixed extract.
(3) Sasa The extracts were prepared by dissolving in water, adding water, and extracting with 80 ~ 90 ℃ for 60 hours by vacuum extractor.
(4) The myrrh and frankincense (Boswellia) were immersed in vinegar or sake for 24 hours, heat treated at 90 to 140 ° C for 2 hours, and then taken out and dried in a cold wind.
(5) Angelicae Angelicae was peeled off and immersed in salt water for 48 hours, taken out and fried until black.
(6) The method according to any one of the above items (1) to (3), wherein the dried egg yolk powder, the dried myrrh powder of step (4) and boswellia, the prepared Angelica gigas and the dried ginseng, mulberry leaf, Methyl sulfonylmethane and MSM were mixed and pulverized into milling, and then the mixed extract prepared in step (2) and the extract prepared in step (3) were kneaded and kneaded. Then, Ventilation and saccharide) at a temperature of 75 ° C to produce a germicidal formulation with a final moisture content of 5% or less.
Example 1: blood circulation improvement effect
Sprague-Dawley male rats (Orient, Korea) with 5 weeks of age and body weight of 180 to 200 g were purchased and used for the experiment after being acclimated for 1 week. After adaptation, the rats were divided into 5 groups according to the nodule method and cultured for 3 weeks. The breeding was carried out under the conditions of a temperature of 23 ± 2 ° C., a humidity of 50 ± 5% and a 12-hour illumination period. In the above-mentioned five experimental groups, 50 mg of the gonadotropins produced by the method of Preparation Example 1, Comparative Example 1 and Comparative Example 2 were added to the positive control group, the normal control group, the negative control group, 0.5% cholesterol supplemented diet and the 0.5% / kg body weight intake group (Production Example 1-1, Comparative Example 1-1 and Comparative Example 2-1), and the diet is shown in Table 2 below.
In order to confirm the blood circulation improvement effect, the experimental animals were fasted for 24 hours before the end of the experiment, and were anesthetized and lapped with ethyl ether, and then blood was collected from the abdominal aorta. The lipid concentration in the serum was left at room temperature for one hour and centrifuged at 3,000 rpm and 4 ° C for 10 minutes. The results of the measurement through the blood were shown through the average value of the measured values in 10 animals in each group.
(Triglyceride, total-cholesterol, HDL-cholesterol, LDL-cholesterol, and cholesterol) in the isolated serum to analyze the effect of the intake of the gonads on blood lipid levels. The triglyceride content, total cholesterol content, HDL-cholesterol content and LDL-cholesterol content are shown in Table 3 by using a dry chemistry analyzer 3500i (Fuji, Japan) using a slide for automated measurement (FUJI FILM, Japan) .
As shown in Table 3 above, the content of triglyceride was increased by about 60% in the negative control group consuming the cholesterol diet compared with the positive control, and the total cholesterol content was increased by more than 100% in the case of the total cholesterol content Respectively. From the above results, it can be seen that when the high cholesterol diet is performed, the blood cholesterol content rapidly increases, and the diseases caused by excessive cholesterol intake, such as hyperlipemia, fatty liver, angina pectoris, arteriosclerosis, heart disease and thrombosis, Able to know.
On the other hand, when the cholesterol diet and the gonads of Preparation Example 1, Comparative Example 1 and Comparative Example 2 were taken together, the blood fat content was decreased. Particularly, in the case of the germinated food intake group (Preparation Example 1-1) of Production Example 1 produced by the method of the present invention, the amount of lipid reduction was significantly lower than that of the germinated food intake group of Comparative Examples 1 and 2 -1), indicating that the gonad cycle of Production Example 1 of the present invention is effective in reducing blood lipid and cholesterol.
In addition, the HDL-cholesterol content in the serum was found to be lower in the negative control group in which the cholesterol diet was performed than in the positive control group. On the other hand, when the gonads of Preparation Example 1 and Comparative Examples 1 and 2 were ingested, it was confirmed that the HDL content was increased. HDL-cholesterol is known to be effective in improving and preventing arteriosclerosis by lowering blood cholesterol concentration. Therefore, it was found that the ingestion of the gonads of the present invention helps to improve cholesterol. On the other hand, LDL-cholesterol levels were significantly higher in the negative control group treated with cholesterol than in the positive control group. On the other hand, the LDL-cholesterol content in the gonad salt-fed group was lower than that in the negative control group. In particular, the gonad cycle of Preparation Example 1 was significantly lower than that of the gonadotropins of Comparative Examples 1 and 2 in the case of diseases associated with decreased blood circulation due to excessive cholesterol intake It has been confirmed that there is an excellent effect for improvement and prevention
Example 2: Sensory evaluation
The sensory test was carried out on 20 persons who were trained in the germinated ginseng prepared by the method of Preparation Example 1 and Comparative Examples 1 and 2. The results are shown in Table 4 below. The sensory test items were evaluated for color, flavor, taste, and overall acceptability. The scores were recorded on a 5-point scale using the following criteria. 5: very good, 4: good, 3: normal, 2: bad, 1: very bad.
As a result, as shown in Table 4, in the preference for color, no significant difference was observed in all the germplasm, but in the preference for flavor and taste, the germplasm of Preparation Example 1 of the present invention showed better preference. It was also found that the germplasm of Production Example 1 of the present invention got a better score even in the overall preference, and that the germplasm of Production Example 1 had no pungent taste and odor peculiar to the material, and was not burdensome to eat.
Claims (4)
(b) preparing an extract by adding water to a spatula, strawberry, mistletoe, sea tangle and licorice;
(c) immersing the myrrh and oriental in vinegar or alcohol, heat treating the myrrh and oriental matter, removing the myrrh and oriental matter, and drying;
(d) immersing the true Angelica gigas in a salt water, taking it out and preparing it for roasting; And
(e) mixing the dry myrrh powder and the oriental preparation of step (c), the prepared Angelica gigas and the brown rice embryo powder prepared in step (d), the dried ginseng, the mulberry leaf, the kneader and the pepper and the dimethyl sulfone, mixing the prepared mixed extract prepared in step (a) with the extract prepared in step (b), kneading the same, and washing and drying the mixture.
(a) water is added to 130 ~ 180 g of bellflower, 140 ~ 210 g of onion and 130 ~ 190 g of dodec, and then the extract is pulverized to prepare a mixed extract;
(b) preparing an extract by adding water to 110 to 170 g of stain saddle, 110 to 170 g of strawberry, 110 to 170 g of mistletoe, 110 to 170 g of sea tangle, and 110 to 160 g of licorice;
(c) immersing 160-240 g of myrrh and 120-170 g of myrrh in vinegar or alcohol, heat-treating, then taking out and drying;
(d) immersing 130 to 180 g of Angelica gigas Nakai in salt water, taking out and preparing for roasting; And
(e) 150 to 220 g of the dry myrrh powder and the scent of step (c) prepared in the above step (d), and 120 to 180 g of the mulberry leaf, 120 to 180 g of the mulberry leaf 115 to 175 g of carnauba wax and 115 to 175 g of dimethyl sulfone are mixed and powdered. The mixed extract prepared in step (a) and the extract prepared in step (b) are mixed and kneaded, ≪ RTI ID = 0.0 > 1, < / RTI >
(a) Water is added to 130 to 180 g of bellflower, 140 to 210 g of onion, 130 to 190 g of onion, and the mixture is extracted at 50 to 60 ° C for 66 to 78 hours, followed by pulverizing the extracted foil and the extract to prepare a mixed extract ;
(b) Water was added to 110 to 170 g of stain saddle bed, 110 to 170 g of strawberry, 110 to 170 g of mistletoe, 110 to 170 g of sea tangle, 110 to 160 g of licorice, and extracted at 80 to 90 ° C for 55 to 65 hours. ;
(c) immersing 160 to 240 g of mols and 120 to 170 g of mushroom in vinegar or sake for 20 to 28 hours, followed by heat treatment at 90 to 140 ° C for 1 to 3 hours, and then taking out and drying;
(d) immersing 130 to 180 g of Angelica gigas Nakai in brine for 44 to 52 hours, taking out and preparing for roasting; And
(e) 150 to 220 g of the dry myrrh powder and the scent of step (c) prepared in the above step (d), and 120 to 180 g of the mulberry leaf, 120 to 180 g of the mulberry leaf 115 to 175 g of carnauba wax and 115 to 175 g of dimethyl sulfone are mixed and powdered. The mixed extract prepared in step (a) and the extract prepared in step (b) are mixed and kneaded, ≪ RTI ID = 0.0 > 1, < / RTI >
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160030685A KR101644333B1 (en) | 2016-03-15 | 2016-03-15 | Method for producing uncooked food pill containing myrrh and frankincense and uncooked food pill produced by the same method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160030685A KR101644333B1 (en) | 2016-03-15 | 2016-03-15 | Method for producing uncooked food pill containing myrrh and frankincense and uncooked food pill produced by the same method |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101644333B1 true KR101644333B1 (en) | 2016-08-01 |
Family
ID=56707013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160030685A KR101644333B1 (en) | 2016-03-15 | 2016-03-15 | Method for producing uncooked food pill containing myrrh and frankincense and uncooked food pill produced by the same method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101644333B1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010084485A (en) * | 2000-02-25 | 2001-09-06 | 정두순 | Method of preparing herbal relievers for neuralgia and arthritis. |
KR20090127970A (en) * | 2008-06-10 | 2009-12-15 | 김윤영 | Uncooked food pill and its manufacturing process |
KR20120134312A (en) * | 2011-06-02 | 2012-12-12 | 박춘일 | Samulgamrihwan |
-
2016
- 2016-03-15 KR KR1020160030685A patent/KR101644333B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010084485A (en) * | 2000-02-25 | 2001-09-06 | 정두순 | Method of preparing herbal relievers for neuralgia and arthritis. |
KR20090127970A (en) * | 2008-06-10 | 2009-12-15 | 김윤영 | Uncooked food pill and its manufacturing process |
KR20120134312A (en) * | 2011-06-02 | 2012-12-12 | 박춘일 | Samulgamrihwan |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102136052B1 (en) | Composition for Liver Protection Containing Hub Extract and Beverage Thereof | |
KR102078461B1 (en) | Food additives | |
Tarantul et al. | Onion (lat. Állium cépa) | |
KR101845388B1 (en) | Beverage composition with the extract of aged onion and the concentrate of wild genseng fruit | |
KR100959559B1 (en) | Mudfish curry containing mudfish powder and method for preparing the same | |
KR101447900B1 (en) | Chinese medicine kalguksu and sujebi, and a method for manufacturing the same | |
KR101163564B1 (en) | Manufacturing method of soybean paste and soybean paste manufactured thereby | |
KR101955770B1 (en) | a functional kimchi making method and the kimch using thereof | |
KR101878413B1 (en) | Healthy mixed drinks using onion skin and herbal ingredients and their preparation method | |
KR101764306B1 (en) | The method for manufacturing of tea | |
JP2018535673A (en) | Lactic acid bacteria fermentation whole garlic manufacturing method | |
KR101768612B1 (en) | Food composition for improving liver function and method of health tea using thereof | |
KR101808406B1 (en) | Method for health food using turmeric, rice bran | |
KR101644333B1 (en) | Method for producing uncooked food pill containing myrrh and frankincense and uncooked food pill produced by the same method | |
KR102517751B1 (en) | Bamboo salt Laver-bugak comprising Ginkgo and Bellflower and Manufacturing method of the same | |
CN107494938A (en) | A kind of Chinese herbal medicine mixed feed for improving beef cattle immunity and preparation method thereof | |
KR101661744B1 (en) | health assistance food using soy-bean paste and brown rice, manufacturing method thereof | |
KR20190006650A (en) | Method for manufacturing a Seasoning crab sauce | |
CN104431934B (en) | A kind of tea-seed oil mashed garlic condiment | |
KR102082115B1 (en) | Manufacturing method of healthy foods using protaetia brevitarsis | |
KR101872937B1 (en) | Manufacturing method of Vitamin Composition | |
KR20200112527A (en) | Antibacterial sauce and method of manufacturing the same | |
KR20150016449A (en) | A composite for health functional food comprising panax ginseng, salicornia europaea, corylopsis coreana and erythronium japonicum | |
KR101871452B1 (en) | The Opuntia humifusa beverages containing lotus root element method. | |
KR101773251B1 (en) | The manufacturing method of making healthcare compositions comprising fermented Cudrania tricuspidata extracts and herbal medicines Abalone extracts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |